X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with Hindustan Unilever - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs HIND. UNILEVER - Comparison Results

HIND. UNILEVER 
   Change

HUL, the largest FMCG company in the country constitutes 13% of the industry valued at Rs. 1.6 trillion (AC Nielsen). It is present in over 20 distinct categories in Home & Personal Care Products and Foods & Beverages. Revenue share of the various pr... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES HIND. UNILEVER AMAR REMEDIES/
HIND. UNILEVER
 
P/E (TTM) x -0.5 66.3 - View Chart
P/BV x 0.1 47.8 0.1% View Chart
Dividend Yield % 0.0 1.2 -  

Financials

 AMAR REMEDIES   HIND. UNILEVER
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
HIND. UNILEVER
Mar-18
AMAR REMEDIES/
HIND. UNILEVER
5-Yr Chart
Click to enlarge
High Rs1641,415 11.6%   
Low Rs86899 9.6%   
Sales per share (Unadj.) Rs261.6164.2 159.3%  
Earnings per share (Unadj.) Rs17.424.1 72.1%  
Cash flow per share (Unadj.) Rs22.326.5 84.0%  
Dividends per share (Unadj.) Rs020.00 0.0%  
Dividend yield (eoy) %01.7 0.0%  
Book value per share (Unadj.) Rs100.733.6 299.4%  
Shares outstanding (eoy) m26.162,164.53 1.2%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.57.0 6.8%   
Avg P/E ratio x7.247.9 15.0%  
P/CF ratio (eoy) x5.643.6 12.9%  
Price / Book Value ratio x1.234.4 3.6%  
Dividend payout %082.9 0.0%   
Avg Mkt Cap Rs m3,2702,504,686 0.1%   
No. of employees `000NA5.7 0.0%   
Total wages/salary Rs m16318,600 0.9%   
Avg. sales/employee Rs ThNM62,087.3-  
Avg. wages/employee Rs ThNM3,248.9-  
Avg. net profit/employee Rs ThNM9,126.6-  
INCOME DATA
Net Sales Rs m6,844355,450 1.9%  
Other income Rs m213,840 0.5%   
Total revenues Rs m6,865359,290 1.9%   
Gross profit Rs m1,13174,990 1.5%  
Depreciation Rs m1285,200 2.5%   
Interest Rs m398260 153.1%   
Profit before tax Rs m62673,370 0.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-330 15.2%   
Tax Rs m12120,790 0.6%   
Profit after tax Rs m45552,250 0.9%  
Gross profit margin %16.521.1 78.3%  
Effective tax rate %19.328.3 68.2%   
Net profit margin %6.614.7 45.2%  
BALANCE SHEET DATA
Current assets Rs m4,904116,600 4.2%   
Current liabilities Rs m3,58188,870 4.0%   
Net working cap to sales %19.37.8 247.8%  
Current ratio x1.41.3 104.4%  
Inventory Days Days12426 481.5%  
Debtors Days Days10013 744.5%  
Net fixed assets Rs m1,68949,890 3.4%   
Share capital Rs m2622,160 12.1%   
"Free" reserves Rs m2,35870,650 3.3%   
Net worth Rs m2,63572,810 3.6%   
Long term debt Rs m5070-   
Total assets Rs m6,862178,620 3.8%  
Interest coverage x2.6283.2 0.9%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.02.0 50.1%   
Return on assets %12.429.4 42.3%  
Return on equity %17.371.8 24.1%  
Return on capital %31.0100.7 30.8%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2733,870 7.1%   
Fx outflow Rs m212,850 0.0%   
Net fx Rs m271-8,980 -3.0%   
CASH FLOW
From Operations Rs m-31360,640 -0.5%  
From Investments Rs m-489-10,680 4.6%  
From Financial Activity Rs m769-49,750 -1.5%  
Net Cashflow Rs m-33210 -15.5%  

Share Holding

Indian Promoters % 25.5 0.0 -  
Foreign collaborators % 0.0 67.3 -  
Indian inst/Mut Fund % 9.2 4.1 224.4%  
FIIs % 0.0 14.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 14.5 450.3%  
Shareholders   13,061 322,351 4.1%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   MARICO LTD  RELAXO FOOTWEARS  BATA INDIA  ARCHIES LTD  GILLETTE INDIA  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 8-QTR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS